Business Context and Reporting Period
Company: The Clorox Company (CLX)
Filing Type: Form 8-K (Current Report)
Report Date: August 1, 2024
Reporting Period: Fourth quarter and fiscal year ended June 30, 2024
This filing announces the release of financial results for the fourth quarter and full fiscal year 2024. The full press release and supplemental financial information are incorporated by reference as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided text serves as a cover sheet and index for the financial results but does not contain specific numerical data.
- Revenue, Profit, Cash Flow, Margins: Not provided in this text; refer to Exhibit 99.1.
- Debt and Liquidity: Not provided in this text; refer to Exhibit 99.2.
Material Changes and Corporate Actions
Divestiture Announcement: The Company announced it has entered into a definitive agreement to divest its Better Health Vitamins, Minerals and Supplements business.
Guidance, Outlook, and Risks
Specific guidance, management commentary, risk factors, or contingencies are not detailed in this filing text. Investors should review the attached press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) for these details.
Investor Verification Checklist
- Review Exhibit 99.1 for specific Q4 and FY2024 revenue, earnings, and margin figures.
- Examine Exhibit 99.2 for supplemental liquidity and debt metrics.
- Verify the terms and expected closing timeline of the Better Health business divestiture.
- Check for any updated fiscal year guidance provided in the press release.